Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
$45.88
$45.88
$43.37
$59.10
$5.51MN/A2,747 shsN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
$1.61
+3.8%
$1.47
$1.02
$5.52
$6.30M2.7577,231 shs470,600 shs
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
$0.68
-1.8%
$0.65
$2.08
$4.41
$5.84M-0.2639,605 shs29,172 shs
PWRCOR stock logo
PWCO
PWRCOR
$0.01
$0.01
$0.00
$0.06
$1.68M1.794,578 shsN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
0.00%0.00%0.00%0.00%0.00%
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
+3.84%+18.35%+15.98%-5.88%-9.60%
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
-1.75%+6.44%+7.64%-12.52%-82.53%
PWRCOR stock logo
PWCO
PWRCOR
0.00%+16.18%+12.86%-48.03%-79.80%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
$45.88
$45.88
$43.37
$59.10
$5.51MN/A2,747 shsN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
$1.61
+3.8%
$1.47
$1.02
$5.52
$6.30M2.7577,231 shs470,600 shs
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
$0.68
-1.8%
$0.65
$2.08
$4.41
$5.84M-0.2639,605 shs29,172 shs
PWRCOR stock logo
PWCO
PWRCOR
$0.01
$0.01
$0.00
$0.06
$1.68M1.794,578 shsN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
0.00%0.00%0.00%0.00%0.00%
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
+3.84%+18.35%+15.98%-5.88%-9.60%
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
-1.75%+6.44%+7.64%-12.52%-82.53%
PWRCOR stock logo
PWCO
PWRCOR
0.00%+16.18%+12.86%-48.03%-79.80%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
0.00
N/AN/AN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
0.00
N/AN/AN/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
0.00
N/AN/AN/A
PWRCOR stock logo
PWCO
PWRCOR
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
N/AN/AN/AN/AN/AN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
$1.65M3.96N/AN/A$4.10 per share0.39
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/AN/AN/AN/A$1.50 per shareN/A
PWRCOR stock logo
PWCO
PWRCOR
$100K16.84N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
N/AN/A0.00N/AN/AN/AN/AN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
-$610KN/A0.00N/AN/AN/AN/AN/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
-$12.47MN/A0.00N/AN/AN/A-189.12%-122.31%11/5/2025 (Estimated)
PWRCOR stock logo
PWCO
PWRCOR
-$80KN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
N/A0.00%N/AN/AN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
N/AN/AN/AN/AN/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/AN/AN/AN/AN/A
PWRCOR stock logo
PWCO
PWRCOR
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
N/AN/AN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
N/A
36.88
36.88
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/A
2.41
2.41
PWRCOR stock logo
PWCO
PWRCOR
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
JJU
iPath Series B Bloomberg Aluminum Subindex Total Return ETN
2,020120,000N/ANot Optionable
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
84.06 million1.50 millionNot Optionable
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
108.62 million8.53 millionNot Optionable
PWRCOR stock logo
PWCO
PWRCOR
N/A213.20 million82.72 millionNot Optionable

Recent News About These Companies

PwrCor, Inc. (PWCO)
Prince William County, VA star_ratehome
Prince William County, VA & Pollenstar_ratehome
PwC Australia investigating former CEO Luke Sayers
PwC paid for tax officer’s Paris trip

Media Sentiment Over Time

iPath Series B Bloomberg Aluminum Subindex Total Return ETN NYSEARCA:JJU

$45.88 0.00 (0.00%)
As of 06/14/2023

The investment seeks to replicate, net of expenses, the Shiller Barclays CAPETM US Core Sector Index. The index seeks to provide a notional long exposure to the top four relatively undervalued U.S. equity sectors that also exhibit relatively strong price momentum. It incorporates the CAPE (Cyclically Adjusted Price Earnings) ratio to assess equity market valuations of nine sectors on a monthly basis and to identify the relatively undervalued sectors represented in the S&P 500.

Magic Empire Global stock logo

Magic Empire Global NASDAQ:MEGL

$1.61 +0.06 (+3.84%)
As of 09/10/2025 03:58 PM Eastern

Magic Empire Global Limited engages in the provision of corporate finance advisory services and underwriting services in Hong Kong. The company provides initial public offering sponsorship, financial and independent financial advisory, post-listing compliance advisory, and underwriting services by acting as global coordinator, bookrunner, lead manager, or underwriter. It also offers corporate services, which include accounting and financial reporting advisory, company secretarial services, internal control enhancement, investor relations advisory, and other consulting services. The company was incorporated in 2016 and is headquartered in Central, Hong Kong.

NeuroBo Pharmaceuticals stock logo

NeuroBo Pharmaceuticals NASDAQ:NRBO

$0.68 -0.01 (-1.75%)
As of 09/9/2025

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

PWRCOR stock logo

PWRCOR OTCMKTS:PWCO

$0.0079 0.00 (0.00%)
As of 09/9/2025

PwrCor, Inc. provides energy infrastructure and alternative energy solutions in the United States. The company manages infrastructure projects for commercial and institutional customers. Its projects include a combination of energy infrastructure components, including electrical power generation, steam production, or chilled water production projects, as well as the infrastructure to distribute these services. The company also commercializes engine technology that converts low-grade heat to mechanical energy for power generation. It serves domestic non-profit institutions and organizations; the waste-heat-to-energy and geothermal marketplace; and the independent power producer market. The company was formerly known as Receivable Acquisition & Management Corporation and changed its name to PwrCor, Inc. in March 2017. PwrCor, Inc. is headquartered in New York, New York.